Literature DB >> 33786728

Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China.

Yan Xu1, Qing Wang2, Kaihu Yao2, Fang Dong3, Wenqi Song3, Gang Liu4, Baoping Xu5, Wei Shi2, Yue Li2, Kechun Li1, Yingchao Liu1, Suyun Qian6.   

Abstract

Invasive pneumococcal disease (IPD) is associated with significant morbidity and mortality. However, limited studies have reported clinical features of IPD cases among Chinese children. This study aimed to evaluate clinical characteristics as well as serotype distribution of hospitalized IPD children in Beijing, China. Children with confirmed IPD were retrospectively recruited from January 2014 to December 2019. Clinical data were gathered from medical records, and serotypes of Streptococcus pneumoniae isolates were detected. Clinical differences between deaths and survivors were also compared, and risk factors associated with death were determined. Of sixty-eight children diagnosed with IPD, 58 (85.3%) were < 5 years. 19F was the predominant serotype (23, 33.8%), followed by 19A (14, 20.6%), 14 (12, 17.6%), 23F (5, 7.4%), and non-vaccine serotype (NVT) 15A (3, 4.4%). The coverage rate of 13-valent pneumococcal conjugate vaccine (PCV) was 92.6% (63). After introduction of PCV-13, there was a significant increase of IPD due to NVTs (p = 0.047). Sixteen (23.5%) children died, and diagnoses of 11 (68.8%) were meningitis. Risk factors for death were < 2 years (odds ratio [OR] [95% confidence interval {CI}]: 6.64 [1.14-32.10]; p = 0.019), altered mental status (OR [95%CI]: 10.10 [2.11-48.31]; p = 0.004), and septic shock (OR [95%CI]: 6.61 [1.11-39.50]; p = 0.038). This study revealed that the case fatality rate of hospitalized IPD children was high in this hospital. Fatal cases were more likely to be children < 2 years, presented with changed mental status and septic shock. Notably, we found that NVTs increased after PCV13 availability in China.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; China; Clinical characteristics; Invasive pneumococcal disease; Serotype distribution

Year:  2021        PMID: 33786728     DOI: 10.1007/s10096-021-04238-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  36 in total

1.  Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.

Authors:  Ashley Makwana; Carmen Sheppard; Ray Borrow; Norman Fry; Nick J Andrews; Shamez N Ladhani
Journal:  Pediatr Infect Dis J       Date:  2018-07       Impact factor: 2.129

2.  Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.

Authors:  Godwin Oligbu; Sarah Collins; Nick Andrews; Carmen L Sheppard; Norman K Fry; Mary P E Slack; Ray Borrow; Shamez N Ladhani
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

3.  Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.

Authors:  Kam Lun Hon; King Hang Chan; Pak Long Ko; Michelle Ho Yan Cheung; Kathy Yin C Tsang; Lawrence C N Chan; Renee W Y Chan; Ting Fan Leung; Margaret Ip
Journal:  J Trop Pediatr       Date:  2018-10-01       Impact factor: 1.165

4.  Disease burden of community acquired pneumonia among children under 5 y old in China: A population based survey.

Authors:  Yan Li; Zhijie An; Dapeng Yin; Yanmin Liu; Zhuoying Huang; Yujie Ma; Hui Li; Qi Li; Huaqing Wang
Journal:  Hum Vaccin Immunother       Date:  2017-04-17       Impact factor: 3.452

Review 5.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

6.  Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.

Authors:  Erik Backhaus; Stefan Berg; Rune Andersson; Gunilla Ockborn; Petter Malmström; Mats Dahl; Salmir Nasic; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-08-03       Impact factor: 3.090

Review 7.  Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.

Authors:  Evelyn Balsells; Laurence Guillot; Harish Nair; Moe H Kyaw
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

8.  Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis.

Authors:  Kaile Chen; Xiyan Zhang; Wei Shan; Genming Zhao; Tao Zhang
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 4.526

9.  Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.

Authors:  Brian Wahl; Katherine L O'Brien; Adena Greenbaum; Anwesha Majumder; Li Liu; Yue Chu; Ivana Lukšić; Harish Nair; David A McAllister; Harry Campbell; Igor Rudan; Robert Black; Maria Deloria Knoll
Journal:  Lancet Glob Health       Date:  2018-07       Impact factor: 26.763

10.  The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.

Authors:  Shinthuja Wijayasri; Kelty Hillier; Gillian H Lim; Tara M Harris; Sarah E Wilson; Shelley L Deeks
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

View more
  1 in total

Review 1.  Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines.

Authors:  Qian-Qian Du; Wei Shi; Dan Yu; Kai-Hu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-11-02       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.